Cellex currently develops, manufactures, and markets 2 versions of a real-time Neuraminidase Inhibitor (NI) assay, one is specific for influenza neuraminidase and the other one is not specific for for influenza neuraminidase. Designed for influenza diagnostic and drug resistance tests, the assay is cost effective, easy-to-use, and more sensitive than leading flu tests currently available on the market.
Welcome to WordPress. This is your first post. Edit or delete it, then start blogging!